Jeffrey J. Teuteberg
Stanford University
195 Papers
667 Citations
Jeffrey J. Teuteberg is an academic researcher from Stanford University. The author has contributed to research in topics: Medicine & Ventricular assist device. The author has an hindex of 40, co-authored 163 publications. Previous affiliations of Jeffrey J. Teuteberg include Cleveland Clinic & University of Pittsburgh.
Chat about Author
Papers
Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound
Yasbanoo Moayedi,Yasbanoo Moayedi,Chun-Po Steve Fan,Maxime Tremblay-Gravel,Robert J.H. Miller,Matsaka Kawana,E.J. Henricksen,Justin Parizo,Rebecca Wainwright,William F. Fearon,Heather J. Ross,Kiran K. Khush,Jeffrey J. Teuteberg +12 more
TL;DR: There is a paucity of data on the impact of donor‐derived atherosclerosis (DA), early discontinuation of prednisone, and early initiation of proliferation signal inhibitors (PSI) as assessed by intravascular ultrasound (IVUS).
9
Infectious complications after heart transplantation in patients screened with gene expression profiling
Yasbanoo Moayedi,Carlos A. Gomez,Chun-Po Steve Fan,Robert J.H. Miller,Paul E. Bunce,Maxime Tremblay-Gravel,Farid Foroutan,Cedric Manlhiot,J. Yee,M. Shullo,Kiran K. Khush,Heather J. Ross,Jose G. Montoya,Jeffrey J. Teuteberg +13 more
TL;DR: In the OAR cohort, the majority of infections occurred within 1 year after transplantation, and the pattern of early infection was consistent with nosocomial and opportunistic causes, whereas later infection was inconsistent with late-onset opportunistic and community-acquired etiologies.
8
Proceedings of the AST heart allocation meeting at the American Transplant Congress, Philadelphia, Pennsylvania, May 4, 2015.
Jon A. Kobashigawa,Jeffrey J. Teuteberg,Monica Colvin,Leah B. Edwards,T. Daun,Minh B. Luu,Jignesh Patel,J.D. Vega,Dan M. Meyer +8 more
TL;DR: The Heart Subcommittee of the OPTN/UNOS Thoracic Committee is exploring a further‐tiered allocation system, devising a “straw man” model as a starting point for modeling analyses and public discussion, with strong support for abolishment of local organ sharing in favor of geographic sharing.
8
Heart failure severity scoring system and medical- and health-related quality-of-life outcomes: the HEMO study.
Kelly V. Liang,Francis Pike,Christos Argyropoulos,Lisa A. Weissfeld,Jeffrey J. Teuteberg,Mary Amanda Dew,Mark Unruh +6 more
TL;DR: The utility of the IDS of the ICED score as a valid prognostic tool for medical and HRQoL outcomes in the HD population with HF is emphasized, especially in perceived physical limitations.
8
Critical Care Cardiology Trials Network (CCCTN): a cohort profile.
Thomas S. Metkus,Vivian M Baird-Zars,Carlos Alfonso,Carlos L. Alviar,Christopher Barnett,Gregory W. Barsness,David N. Berg,Mia Bertic,Erin A. Bohula,James A. Burke,Barry Burstein,Sunit-Preet Chaudhry,Howard A. Cooper,Lori B. Daniels,Christopher B. Fordyce,Shahab Ghafghazi,Michael Goldfarb,Jason N. Katz,Ellen C. Keeley,Norma Keller,Benjamin B. Kenigsberg,Michael C. Kontos,Young-Bae Kwon,Patrick R. Lawler,Evan Leibner,Shuangbo Liu,Venu Menon,P. Elliott Miller,L. Kristin Newby,Connor O'Brien,Alexander Papolos,M. J. Pierce,Rajnish Prasad,Barbara A. Pisani,Brian J. Potter,Robert O. Roswell,Shashank S. Sinha,Kevin S. Shah,Timothy W. Smith,R. Jeffrey Snell,Derek So,Michael A. Solomon,Bradley Ternus,Jeffrey J. Teuteberg,Sean van Diepen,Sammy Zakaria,David A. Morrow +46 more
TL;DR: The CCCTN is a large, prospective registry dedicated to describing processes-of-care and expanding clinical knowledge in cardiac critical illness and will serve as an investigational platform from which to conduct randomized controlled trials in this important patient population.
8